You are here: Accueil Les régions Europe
Envoyé: 22 July 2019
From 21 July 2019 the Prospectus Regulation (Regulation (EU) 2017/1129) will apply in full and directly in all EU Member States (replacing national prospectus legislation). On 12 July 2019, ESMA published updated Q&As relating to the Prospectus Regulation.
The texts of the EU’s new Directive and Regulation on the cross border distribution of investment funds have now been formally published and their key provisions will take effect from 02 August 2021.
Envoyé: 19 July 2019
The Supreme Court has refused permission to appeal in this important mass tort case. Chris Owen and Adam Bristow consider the impact of that decision and how it contrasts with the recent Supreme Court judgment in Vedanta.
Applicants filing computing and telecoms patent applications in the UK could now benefit from quicker and better value-for-money searches.
The Belgian Federal Agency for Medicines and Health Products (FAMHP) has recently issued an administrative circular clarifying the conditions in which healthcare institutions may request and companies may provide gifts, advantages and benefits in the context of public tenders taking place in Belgium.
Download the slides and watch our recent webinar on demand. The fifth call in our SMCR implementation series focuses on understanding the conduct rules and the current regulatory focus on culture and conduct.
The Irish regulator has published the findings from its review of closet tracking.
Envoyé: 18 July 2019
On 21 July 2019 the EU Prospectus Regulation becomes fully effective across the EU and applies to all propsectuses approved on or after that date. This article considers the key changes that the Prospectus Regulation makes to the current prospectus regime for equity issuers.
Following a settlement last week the US Federal Trade Commission has imposed a fine of $5bn on Facebook in relation to its privacy law violations in connection with the Cambridge Analytica scandal. The sheer scale of the fine, more than twice the maximum level possible under GDPR, and the market reaction to it raise a number of interesting questions.
We consider why buy-side insureds are starting to request the exclusion of insurers’ subrogation rights against the buyer’s professional advisors. Are concerns that contribution claims might be made against the seller well founded?
Londres 23 July 2019
Milan 24 July 2019
Londres 25 July 2019
26 July 2019
Afficher tous les événements
Voir tous les supports de formation
© Simmons & Simmons LLP 2019. All rights reserved. Registered in England & Wales Registered Number OC352713
elexica Limited, CityPoint, One Ropemaker Street, London EC2Y 9SS